+187.3%
GSK price history and return analytics
+355.4%
-168.1%
-42.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | VT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.6% | -0.5% | -0.1% | -0.3% |
| 7D | +5.2% | -0.1% | +5.3% | +5.3% |
| 30D | +10.2% | -3.1% | +13.2% | +12.0% |
| 3M | -0.9% | -3.5% | +2.6% | +1.0% |
| 6M | +3.5% | +0.5% | +3.0% | +2.7% |
| YTD | +7.2% | +10.8% | -3.6% | +0.6% |
| 1Y | +12.0% | +11.9% | +0.1% | +4.4% |
| 3Y | +67.3% | +73.0% | -5.6% | +20.3% |
| 5Y | +45.3% | +58.6% | -13.4% | +8.4% |
| 10Y | +101.8% | +219.2% | -117.4% | -2.2% |
| All | +187.3% | +355.4% | -168.1% | +4.2% |
Cumulative growth
Daily Returns
Daily percentage return beside VT.
Daily Out/Under-Performance
Portfolio return minus VT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded VT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling